These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts. Rowley SD, Piantadosi S, Marcellus DC, Jones RJ, Davidson NE, Davis JM, Kennedy J, Wiley JM, Wingard JR, Yeager AM. Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755 [Abstract] [Full Text] [Related]
5. Failure of bone marrow cryopreservation in chronic granulocytic leukemia: relation to excessive granulo-macrophagic progenitor pool. Douay L, Lopez M, Gorin NC, Nauman A, Giarratana MC, Laporte JP, Stachowiak J, Salmon C, Duhamel G. Int J Cell Cloning; 1986 Jul; 4(4):250-62. PubMed ID: 2875118 [Abstract] [Full Text] [Related]
6. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma. Papadakis V, Ferguson KF, Heller G, Kernan NA. Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927 [Abstract] [Full Text] [Related]
7. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Jones RJ, Wagner JE, Celano P, Zicha MS, Sharkis SJ. Nature; 1990 Sep 13; 347(6289):188-9. PubMed ID: 2395470 [Abstract] [Full Text] [Related]
8. Myeloid progenitor cells (CFU-GM) predict engraftment kinetics in autologous transplantation in children. Emminger W, Emminger-Schmidmeier W, Höcker P, Hinterberger W, Gadner H. Bone Marrow Transplant; 1989 Jul 13; 4(4):415-20. PubMed ID: 2673462 [Abstract] [Full Text] [Related]
9. Stem cells from peripheral blood and bone marrow: a comparative evaluation of the hemopoietic potential in the dog. Raghavachar A, Prümmer O, Fliedner TM, Calvo W, Steinbach IB. Int J Cell Cloning; 1983 Sep 13; 1(4):191-205. PubMed ID: 6366082 [Abstract] [Full Text] [Related]
10. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both? Jansen EM, Hanks SG, Terry C, Akard LP, Thompson JM, Dugan MJ, Jansen J. Transfusion; 2007 May 13; 47(5):817-23. PubMed ID: 17465946 [Abstract] [Full Text] [Related]
11. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation. Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A. Exp Hematol; 1993 Mar 13; 21(3):405-410. PubMed ID: 8440338 [Abstract] [Full Text] [Related]
12. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system. Hirao A, Kawano Y, Takaue Y, Suzue T, Abe T, Sato J, Saito S, Okamoto Y, Makimoto A, Kawahito M. Exp Hematol; 1994 Jun 13; 22(6):521-6. PubMed ID: 8187849 [Abstract] [Full Text] [Related]
13. Purification of murine bone-marrow-derived granulocyte-macrophage colony-forming cells. Williams DE, Straneva JE, Shen RN, Broxmeyer HE. Exp Hematol; 1987 Mar 13; 15(3):243-50. PubMed ID: 3817051 [Abstract] [Full Text] [Related]
14. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients. Schneider JG, Crown JP, Wasserheit C, Kritz A, Wong G, Reich L, Norton L, Moore MA. Bone Marrow Transplant; 1994 Dec 13; 14(6):877-84. PubMed ID: 7536069 [Abstract] [Full Text] [Related]